US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

ARDX

Ardelyx (ARDX)

Ardelyx Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARDX

1 2 3 4 5 6 7 8 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
09/05/2024	15:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
07/05/2024	07:01	GlobeNewswire Inc.	Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference	NASDAQ:ARDX	Ardelyx Inc
02/05/2024	15:02	GlobeNewswire Inc.	Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ARDX	Ardelyx Inc
01/05/2024	07:00	GlobeNewswire Inc.	Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings	NASDAQ:ARDX	Ardelyx Inc
18/04/2024	07:00	GlobeNewswire Inc.	Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024	NASDAQ:ARDX	Ardelyx Inc
28/03/2024	15:05	GlobeNewswire Inc.	Ardelyx, Inc. Reports Employment Inducement Grants	NASDAQ:ARDX	Ardelyx Inc
25/03/2024	07:00	GlobeNewswire Inc.	Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy	NASDAQ:ARDX	Ardelyx Inc
05/03/2024	15:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARDX	Ardelyx Inc
27/02/2024	07:00	GlobeNewswire Inc.	Ardelyx to Participate at the Cowen 44th Annual Health Care Conference	NASDAQ:ARDX	Ardelyx Inc
22/02/2024	15:40	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ARDX	Ardelyx Inc
22/02/2024	15:01	GlobeNewswire Inc.	Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:ARDX	Ardelyx Inc
22/02/2024	05:05	IH Market News	U.S. Futures Surge on Nvidia’s Stellar Performance, Global Markets Respond Positively	NASDAQ:ARDX	Ardelyx Inc
13/02/2024	13:12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ARDX	Ardelyx Inc
01/02/2024	07:00	GlobeNewswire Inc.	Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024	NASDAQ:ARDX	Ardelyx Inc
08/01/2024	07:00	GlobeNewswire Inc.	Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities	NASDAQ:ARDX	Ardelyx Inc
03/01/2024	07:03	GlobeNewswire Inc.	Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8	NASDAQ:ARDX	Ardelyx Inc
21/11/2023	07:01	GlobeNewswire Inc.	Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
15/11/2023	15:02	GlobeNewswire Inc.	XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia	NASDAQ:ARDX	Ardelyx Inc
13/11/2023	15:02	GlobeNewswire Inc.	Ardelyx Announces Departure of Board Member	NASDAQ:ARDX	Ardelyx Inc
10/11/2023	07:05	GlobeNewswire Inc.	Ardelyx to Participate at the Jefferies London Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
06/11/2023	07:00	GlobeNewswire Inc.	Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States	NASDAQ:ARDX	Ardelyx Inc
03/11/2023	07:00	GlobeNewswire Inc.	Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023	NASDAQ:ARDX	Ardelyx Inc
31/10/2023	06:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARDX	Ardelyx Inc
31/10/2023	06:00	GlobeNewswire Inc.	Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenue Guidance	NASDAQ:ARDX	Ardelyx Inc
23/10/2023	07:07	GlobeNewswire Inc.	Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023	NASDAQ:ARDX	Ardelyx Inc
18/10/2023	15:02	GlobeNewswire Inc.	Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023	NASDAQ:ARDX	Ardelyx Inc
18/10/2023	14:35	AllPennyStocks.com	Biotech Finds Mid-Week Success Following FDA Announcement	NASDAQ:ARDX	Ardelyx Inc
18/10/2023	08:03	IH Market News	Wednesday’s Wall Street Highlights: ASML, Nvidia, United Airlines, Viking Therapeutics, P&G, and More	NASDAQ:ARDX	Ardelyx Inc
18/10/2023	07:30	Dow Jones News	Ardelyx Shares Rally Premarket on FDA Approval of Xphozah	NASDAQ:ARDX	Ardelyx Inc
17/10/2023	18:44	Dow Jones News	Ardelyx Gets FDA OK for Add-On Therapy for Kidney Disease Patients	NASDAQ:ARDX	Ardelyx Inc

Showing the most relevant articles for your search:NASDAQ:ARDX

1 2 3 4 5 6 7 8 Próxima >

US Dollar vs MXN

Bank of America

Health Care Select Sector

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones